Managing Metastatic Triple-Negative Breast Cancer
Speaker: Lyndsay N. Harris, MD
Get the emerging news on research for metastatic triple-negative breast cancer, or breast cancer that tests negative for estrogen, progesterone and HER2. Learn about standard treatments; cutting-edge therapies like PARP inhibitors and anti-angiogenic medicines; and ways to manage common symptoms and treatment side effects.
Download the Transcript:
LBBCmetastatictriplenegative10.pdf 221.69 kB PDF File
Download the Podcast:
TripleNegativeMets_05.01.10.MP3 16.71 MB MP3 File